Skip to main content

Diabetes Tied to Identifiable Vocal Changes

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 1, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 1, 2023 -- Vocal changes appear to occur in individuals with type 2 diabetes mellitus (T2DM) versus those without diabetes, according to a study published online in the December issue of Mayo Clinic Proceedings: Digital Health.

Jaycee M. Kaufman, from Klick Inc. in Toronto, and colleagues investigated the potential of voice analysis as a prescreening or monitoring tool for T2DM. Voices were compared for 267 participants without diabetes (79 women and 113 men) and those with diabetes (18 women and 57 men).

The researchers observed significant differences between voice recordings of men and women with and without diabetes, both for the entire dataset and in an age-matched and body mass index (BMI)-matched sample. Overall, pitch and pitch standard deviation achieved the highest predictive accuracy. For women, relative average pertubation jitter was also significant, as were intensity and 11-point amplitude perturbation quotient shimmer for men. When combining these features with age and BMI, the optimal prediction models achieved accuracies of 0.75 for women and 0.70 for men in the age-matched and BMI-matched sample.

"Voice analysis shows potential as a prescreening or monitoring tool for T2DM, particularly when combined with other risk factors associated with the condition," the authors write.

Several authors are employees of Klick Inc., the source of funding for the study, and one author is listed as an inventor on two patents for the estimation of blood glucose using voice.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

Small but Important Differences Seen Between Rosuvastatin, Atorvastatin

WEDNESDAY, Oct. 30, 2024 -- There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.